ArticleNature communications2021

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.

Michael Fraser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.